Results 11 to 20 of about 4,119,069 (249)

Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs): Nanostructure of the Glassy State Studied by Electron Paramagnetic Resonance Spectroscopy

open access: yesMolecules, 2022
Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) draw increasing interest as a particular class of ILs that possess unusual physicochemical properties along with simultaneous potentials for pharmaceutical applications.
Olga D. Bakulina   +5 more
doaj   +2 more sources

Structure of the active pharmaceutical ingredient bismuth subsalicylate [PDF]

open access: yes, 2021
Structure determination of pharmaceutical compounds is invaluable for drug development but is challenging for those that form as small crystals with defects.
A. Ken, Inge   +4 more
core   +2 more sources

Computer-aided retrosynthesis planning for greener and optimal synthesis of an active pharmaceutical ingredient [Extended abstract]

open access: yes, 2023
In this study, the state-of-the-art computer-aided retrosynthesis (CAR) tools were used to develop a synthesis protocol for a helicase primase inhibitor active pharmaceutical ingredient (API). The proposed CAR plan resulted in a 7-step synthetic pathway,
Rodolfo Teixeira (14601323)   +1 more
core   +3 more sources

Development of New Isolation and Quantification Method of Piperine from White Pepper Seeds (Piper Nigrum L) Using A Validated HPLC

open access: yesIndonesian Journal of Pharmacy, 2021
Most of the active pharmaceutical ingredients in the pharmaceutical world are obtained from natural ingredients, one of which is white pepper. White pepper seeds (Piper nigrum L.) contain the main alkaloid compound piperine, which has a broad spectrum ...
Nindya Kusumorini   +3 more
doaj   +1 more source

Manufacturing mass intensity: 15 ​Years of Process Mass Intensity and development of the metric into plant cleaning and beyond

open access: yesCurrent Research in Green and Sustainable Chemistry, 2022
The American Chemical Society Green Chemistry Institute (ACS GCI) Pharmaceutical Roundtable is committed to continue to expand and identify elements of small-molecule active pharmaceutical ingredient (API) manufacturing that should be quantified to drive
Colin H. Benison, Philippa R. Payne
doaj   +1 more source

Untargeted LC-QTOF-MS/MS Based Metabolomic Profile Approach of Bacterial Ferment Lysates and Skin Commensal Bacterial Cocktail Ferment Lysates

open access: yesHayati Journal of Biosciences, 2023
Microbial therapy has been increasingly developed in the medical and health fields and has triggered advances in the process of formulating skincare products.
Ahmad Baikuni   +4 more
doaj   +1 more source

Pharmaceutical Evaluation of Levofloxacin Orally Disintegrating Tablet Formulation Using Low Frequency Raman Spectroscopy

open access: yesPharmaceutics, 2023
We evaluated the pharmaceutical properties of levofloxacin (LV) in the form of an orally disintegrating tablet (LVODT) to find a new usefulness of low frequency (LF) Raman spectroscopy.
Yoshihisa Yamamoto   +5 more
doaj   +1 more source

Influence of pH, Temperature and Impurities on the Solubility of an Active Pharmaceutical Ingredient (API) [PDF]

open access: yes, 2010
Solubility, which defines the liquid /solid equilibrium, is a key parameter to control a crystallization process. This work is focused on the effects of pH, temperature and impurities on the aqueous solubility of an Active Pharmaceutical Ingredient (API).
Estime, Nicolas   +7 more
core   +1 more source

Results for active pharmaceutical ingredient, pH and retention status.

open access: yes, 2021
Results for active pharmaceutical ingredient, pH and retention status.
Joyce M. Ondicho (11467141)   +3 more
core   +1 more source

Life Cycle Analysis within Pharmaceutical Process Optimization and Intensification: Case Study of Active Pharmaceutical Ingredient Production [PDF]

open access: yes, 2014
As the demand for new drugs is rising, the pharmaceutical industry faces the quest of shortening development time, and thus, reducing the time to market.
Kralisch, D.   +18 more
core   +2 more sources

Home - About - Disclaimer - Privacy